Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2021
  • Volume: 14
  • Issue: 7

Advances in oral chitosan based nano delivery system for colon targeted drug delivery in inflammatory bowel disease

  • Author:
  • Ganesh Narayan Sharma1, Ch. Praveen Kumar1, Birendra Shrivastava1, B. Kumar2
  • Total Page Count: 6
  • Page Number: 3769 to 3774

1School of Pharmaceutical Sciences, Jaipur National University, Jaipur - 307017, India

2Ratnam Institute of Pharmacy, Pidathapolur (V), SPSR Nellore, Andhra Pradesh, Dt. 524346, India

Online published on 25 August, 2021.

Abstract

Nanomaterials can be used as drug carriers with multiple features, including target delivery triggered by environmental, pH, thermal responses, enhanced biocompatibility, and the ability to cross the blood-brain barrier. Chitosan (CS) is a natural polysaccharide largely obtained from marine crustaceans. It provides drug delivery vector for therapeutic CS and diagnostic CS, owing to its biocompatibility, biodegradability, low toxicity, and structural variability. Derivatives of CS such as quaternized CS, thiolated CS and carboxylated CS have enhanced its effectiveness in oral absorption of macromolecular drugs. This review discusses different forms of nanomaterials generated from CS and its derivatives for controlled drug delivery.

Keywords

Chitosan, Crustaceans, Biocompatibility, Controlled drug delivery